UK AI Fund Eyes Potential Sciences

The UK's Sovereign AI Fund is reportedly considering an investment in Potential Sciences, extending the government's AI strategy into scientific discovery.

What happened

The £500 million Sovereign AI Fund is reportedly in talks to invest in the London-based AI drug-discovery startup and provide it with access to compute capacity.

The prospective equity investment itself is understood to be in the seven-figure range, with additional investors also involved in discussions.

The talks have not been publicly confirmed by the government or the company, so the transaction should not be treated as completed.

Why it matters

Drug-discovery startups need both capital and significant computing resources. A sovereign fund capable of offering both can act differently from a conventional venture investor.

That may be particularly useful in scientific AI, where the cost of training models and running experiments can be high long before a company reaches commercial scale.

The bigger picture

Sovereign AI policy is moving beyond funding foundational models and data centres. Governments are increasingly looking at application layers where AI could strengthen strategic industries such as pharmaceuticals, energy and defence. Potential Sciences would be a useful example of public-backed capital trying to shape where national AI capability is built.